Erasca Inc
NASDAQ:ERAS

Watchlist Manager
Erasca Inc Logo
Erasca Inc
NASDAQ:ERAS
Watchlist
Price: 3.43 USD 1.18% Market Closed
Market Cap: 973.1m USD

Wall Street
Price Targets

ERAS Price Targets Summary
Erasca Inc

Wall Street analysts forecast ERAS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ERAS is 4.99 USD with a low forecast of 1.01 USD and a high forecast of 11.55 USD.

Lowest
Price Target
1.01 USD
71% Downside
Average
Price Target
4.99 USD
45% Upside
Highest
Price Target
11.55 USD
237% Upside
Erasca Inc Competitors:
Price Targets
CGON
CG Oncology Inc
82% Upside
ALCLS
Cellectis SA
60% Upside
EXEL
Exelixis Inc
1% Downside
STOK
Stoke Therapeutics Inc
3% Upside
SPRY
ARS Pharmaceuticals Inc
147% Upside
GBIO
Generation Bio Co
62% Upside
688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
26% Upside
300685
Amoy Diagnostics Co Ltd
42% Upside

Revenue
Forecast

Revenue Estimate
Erasca Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Erasca Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Net Income
Forecast

Net Income Estimate
Erasca Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-44%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ERAS's stock price target?
Price Target
4.99 USD

According to Wall Street analysts, the average 1-year price target for ERAS is 4.99 USD with a low forecast of 1.01 USD and a high forecast of 11.55 USD.

Back to Top